doxorubicin,sotigalimab
apexigen
['apex', 'doxorubicin', 'sotigalimab', 'sarcoma', 'apexigen', '$apgn']
$apgn - apexigen announces phase 2 data evaluating sotigalimab, its cd40 agonist antibody, in combination with doxorubicin in patients with advanced soft tissue sarcoma presented at the american society of clinical oncology (asco) 2023 annual meeting 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.